November 26, 2015
Recommended Topic Related To:


"Almost all of the 41 million estimated contact lens wearers in the United States may be engaging in at least one behavior known to increase their risk of eye infections, according to a report published today by the Centers for Disease Control and"...


How Supplied


ZYMAXID® (gatifloxacin ophthalmic solution) 0.5% solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

Aerobic Gram-Positive Bacteria

Staphylococcus aureus
Staphylococcus epidermidis

Streptococcus mitis
Streptococcus oralis*

Streptococcus pneumoniae

Aerobic Gram-Negative Bacteria

Haemophilus influenzae

*Efficacy for this organism was studied in fewer than 10 infections.


Patients 1 year of age or older: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times on Day 1. Instill one drop two to four times daily in the affected eye(s) while awake on Days 2 through 7.


Dosage Forms And Strengths

Five (5) mL bottle containing 2.5 mL of a 0.5% sterile topical ophthalmic solution.

Storage And Handling

ZYMAXID® (gatifloxacin ophthalmic solution) 0.5% is supplied sterile in a white, low density polyethylene (LDPE) bottle with a controlled dropper tip, and a tan, high impact polystyrene (HIPS) cap in the following size:

2.5 mL in 5 mL bottle: NDC 0023-3615-25


Store at 15°-25°C (59°-77°F). Protect from freezing.

Allergan, Inc, Irvine, CA 92612, U.S.A. Revised: Jan 2014

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 6/4/2015

How Supplied

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

WebMD Daily

Get breaking medical news.